Patients with respiratory and gastrointestinal tract infection frequently have been treated by OPD and ER in the early stage. Some patients do not have an admission or could not wait for hours and days in the result of clinical suspicion and primary medical care. Patient’s admission might do for symptoms observation including microbiological culture testing or molecular testing, if necessary1.
Because of high sensitivity and specificity, molecular biology testing has an important role in infectious diagnosis. However, mostly molecular biology testing has spent time and cost in an advanced laboratory. Patients see a doctor or admit to the test results; it will cost time-consuming and high expenses1.
Automatic syndromic molecular testing could highly detect a range of common pathogens in each syndromic group. For example, patients with respiratory symptoms could test with simple influenza profiles (Influenza A, Influenza B, and RSV)2 and a complex respiratory syndrome with 22 pathogens (e.g. Influenza A, Influenza B, RSV, Mycoplasma pneumonia and Rhinovirus)3. These tests could reduce the waiting time of patients, unnecessarily used of antibiotic and especially help physician decision for precise medication4.
N Health Molecular Laboratory provides STAT molecular syndromic testing with US-FDA approved systems. All of the systems have a number of publications and world-class hospitals as technical references and reference sites including Mayo Clinic (US) and UK NHS. N Health Molecular Laboratory can release result within 1-4 hours after receiving specimen as following tests list.
Note: Respiratoty Pathogen Panel (RP22) (STAT) is Available on 1 April 2019.
*Above turnaround time does not includw logistic time. For BDMS network hospitals, Please contact N Health Laboratory located at your hospitals.
- Youngs J, et al. Implementation of the cobas Liat influenza point-of-care test into an emergency department during a high-incidence season: a retrospective evaluation following real-world implementation. Journal of Hospital Infection. 2018 Dec 16.
- Banerjee D, et al. Comparison of six sample-to-answer influenza A/B and respiratory syncytial virus nucleic acid amplification assays using respiratory specimens from children. Journal of clinical microbiology. 2018 Nov 1;56(11):e00930-18.
- Leber AL, et al. Multicenter evaluation of BioFire FilmArray respiratory panel 2 for detection of viruses and Bacteria in nasopharyngeal swab samples. Journal of clinical microbiology. 2018 Jun 1;56(6):e01945-17.
- Buss SN, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. Journal of clinical microbiology. 2015 Mar 1;53(3):915-25.